(Press-News.org) Thursday, December 13, 2012, Cleveland: Cleveland Clinic researchers from the Lerner Research Institute have uncovered two new genes associated with Cowden syndrome (CS) according to a new study, published today in the online version of the American Journal of Human Genetics.
Cowden syndrome is a difficult-to-recognize, under-diagnosed condition that carries high risks of breast, thyroid, and other cancers. The discovery of the two new genes – led by Charis Eng, MD, Ph.D., Chair and Founding Director of the Cleveland Clinic's Lerner Research Institute's Genomic Medicine Institute – will promote diagnosis and clinical management of the disease, while also assisting in predictive genetic testing and genetic counseling.
Researchers performed genetic sequencing on DNA from individuals with CS who have none of the known genetic alterations associated with CS. State-of-the-art technology was used to identify a high prevalence of mutations in the PIK3CA and AKT1 genes, which are involved in cancer-related signaling pathways.
In tracing the root causes of CS, Dr. Eng has previously identified many genetic alterations that promote the disease, beginning with mutations in the first gene ever to be associated with CS, the tumor suppressor, PTEN, along with the SDHB/D and KLLN genes, identifying their connection with PTEN in cancer.
"Gene-enabled risk assessment and management begins with the identification of all the genes that, when mutated, account for as many or all the individuals with a particular syndrome, in this case CS," said Dr. Eng. "We started with only PTEN, and now we know that SDHB/D, KLLN, PIK3CA and AKT1 account for CS. Each also brings differing risks of breast, thyroid and other cancers, and so this discovery directly aids genetic counseling and clinical management."
This research comes on the heels of two new discoveries by Dr. Eng, both related to Cowden syndrome and the PTEN gene, that were recently published in the Journal of Clinical Endocrinology & Metabolism.
In a Nov. 1 paper, Dr. Eng and her team reported on uncovered, untapped, diagnostic and prognostic pathways for cancers related to the compromised PTEN tumor suppressor.
This discovery that PTEN disrupts cancer signaling pinpoints a novel target for future treatment and diagnosis. This type of location-specific strategy is important in both heritable and sporadic cancers.
In another paper published Dec. 1, Dr. Eng and her team identified a screening biomarker in thyroid cancers that revealed inherited predisposition in Cowden syndrome patients. With the increasing incidence of thyroid cancer over the last few years, having a biomarker to screen for an inherited mutated PTEN tumor suppressor gene would accelerate follow-up for affected individuals.
After a five-year, multi-center study of patients with Cowden syndrome and Cowden-like syndrome, characterized in part by PTEN mutations, researchers have concluded that a simple blood test may screen for individuals carrying increased cancer risk. Until now, only four clinical factors were known to predict an inherited PTEN mutation – and this study's blood test out-predicts them all. Future studies testing thyroid tissue itself may reveal additional biomarkers.
INFORMATION:
Charis Eng, M.D., Ph.D., is Chair and Founding Director of the Cleveland Clinic's Lerner Research Institute's Genomic Medicine Institute, and founding Director of the institute's clinical component, the Center for Personalized Genetic Healthcare. Dr. Eng's research interests may be broadly characterized as clinical cancer genetics translational research. For more information visit: http://www.lerner.ccf.org/gmi/eng/
Research reported in this publication was supported by was funded by the National Cancer Institute of the National Institutes of Health under award number P01CA124570 and R01CA118980, and the Breast Cancer Research Foundation. Dr. Eng holds an American Cancer Society Clinical Research Professorship.
About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S .News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals in its annual "America's Best Hospitals" survey. About 2,800 full-time salaried physicians and researchers and 11,000 nurses represent 120 medical specialties and subspecialties. Cleveland Clinic Health System includes a main campus near downtown Cleveland, eight community hospitals and 18 Family Health Centers in Northeast Ohio, Cleveland Clinic Florida, the Lou Ruvo Center for Brain Health in Las Vegas, Cleveland Clinic Canada, and opening in 2013, Cleveland Clinic Abu Dhabi. In 2010, there were 4 million visits throughout the Cleveland Clinic health system and 167,000 hospital admissions. Patients came for treatment from every state and from more than 100 countries. Visit us at www.clevelandclinic.org. Follow us at www.twitter.com/ClevelandClinic.
Editor's Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.
END
LONDON – Globally, health advances present most people with a devastating irony: avoid premature death but live longer and sicker.
That's one of the main findings from the Global Burden of Disease Study 2010 (GBD 2010), a collaborative project led by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. The findings are being announced at the Royal Society in London on Dec. 14 and published in The Lancet, the first time the journal has dedicated an entire triple issue to one study. The seven scientific papers and accompanying commentaries ...
Over 9 million people died as a consequence of high blood pressure in 2010, making it the health risk factor with the greatest toll worldwide, say experts.
Smoking and alcohol use have also overtaken child hunger in the last two decades to become the second and third leading risks globally, according to a study estimating the disease burden attributable to 43 risk factors in 1990 and 2010.
The analysis was undertaken by an international consortium of scientists as part of the Global Burden of Disease Study 2010, which is published in The Lancet today.
"Overall we're ...
Boston, MA — No matter where they live, how much education they have, or what their incomes are, people have very similar perceptions on the impact of diseases and injuries.
This finding – counter to the prevailing belief that people throughout the world view different health conditions in very different ways depending on their culture or individual circumstances – is part of a collaborative project, the Global Burden of Disease Study 2010 (GBD 2010). GBD 2010, launched by Harvard School of Public Health (HSPH), the Institute for Health Metrics and Evaluation (IHME) ...
Scientists have discovered new evidence about the evolution of viruses, in work that will change our understanding about the control of infectious diseases such as winter flu.
Researchers at the University of Exeter's conducted experiments to manipulate a virus to see if it could evolve the ability to switch its behaviour according to how many other viruses infect a host.
Previous research has focussed on trying to force harmful microbes to become less threatening to human health as they evolve. But the new research, which was carried out in collaboration with the ...
New York, NY, December 13, 2012— Despite important progress in research and development (R&D) for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases, highlighting the 'fatal imbalance' between global disease burden and drug development for some of the world most devastating illnesses, said Doctors Without Borders/Médecins Sans Frontières (MSF) and the Drugs for Neglected Diseases initiative (DNDi), in an analysis to be presented today at an international conference aimed ...
Mountain View, Calif. – December 13, 2012 -- 23andMe, the leading personal genetics company, today announced the availability of Ancestry Composition, a new feature that provides state-of-the-art geographic illustration of an individual's ancestral origins. Using 22 reference populations, the feature indicates what percent of a person's ancestry comes from various regions around the world. The analysis includes DNA inherited from all ancestors on both sides of the family. The results reflect where an individual's ancestors lived going back approximately 500 years.
Ancestry ...
Scientists have identified a new mutation in the gene that causes the inherited disease known as Alpha-1 Antitrypsin Deficiency (Alpha-1), which affects roughly one in 2,500 people of European descent.
Alpha-1 can lead to serious lung disease in adults, or liver disease at any age.
The finding extends understanding of Alpha-1 at the molecular level, potentially leading to new drug development and better diagnostic tools.
Dr Darren Saunders from Sydney's Garvan Institute of Medical Research and Professor Vanessa Hayes, from the J. Craig Venter Institute in San Diego, ...
Primary sources publisher, Adam Matthew, has announced the release of the fourth section of its highly renowned Victorian Popular Culture Portal. "Moving Pictures, Optical Entertainments and the Advent of Cinema" explores the cultural history of optical entertainments from the late 18th century to the early 20th century, bringing to life the rich cultural and scientific history from which cinema was born.
From shadow puppets to dioramas, and from zoetropes to Hollywood, the long and varied evolution of visual entertainments is represented through objects, ephemera and ...
MAMMALS could be at a greater risk of extinction due to predicted increases in extreme weather conditions, states a paper published today by the Zoological Society of London (ZSL).
Scientists have mapped out land mammal populations, and overlapped this with information of where droughts and cyclones are most likely to occur. This allowed them to identify species at high risk of exposure to extreme weather. The paper, published this week in the journal Conservation Letters, describes the results of assessing almost six thousand species of land mammals in this way.
Lead ...
A hearing system component thought to be unique in toothed whales like dolphins has been discovered in insects, following research involving the University of Strathclyde.
The research is challenging ideas about how a large group of insects including crickets and katydids hear, revealing the unexpected similarity to toothed whale hearing.
Scientists from the School of Biological Sciences at The University of Auckland, with colleagues from Plant & Food Research in New Zealand, led the research with engineers from the University of Strathclyde working on the biomechanical ...
